View recorded webinars
CDPH is overseeing the registration for the COVID-19 vaccination program in California. Due to limited supplies of vaccine currently, registration for the COVID-19 vaccine program in California is limited at this time to healthcare providers and other entities serving populations in the initial priority groups, see CDPH Notice to Local Health Officers: Allocation and Distribution of COVID-19 Vaccine. In order for healthcare provider facilities to participate (receive and/or administer vaccine) they must:
Providers or organizations interested in receiving and administering the COVID-19 vaccine are encouraged to enroll or update their information in CAIR now. Visit http://cairweb.org/enroll-now for information about how to enroll. Providers or organizations that are already enrolled in CAIR will be asked to provide their organizational IIS ID during the registration process. For any questions about enrollment contact the local CAIR Representative or the CAIR Help Desk.
Visit CDPH California COVID-19 Vaccination Program for more information on vaccine distribution, availability, enrollment and training requirements, and planning questions and answers.
National and State Planning Resources
CDC: COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals. Includes general and COVID-19 specific vaccination educational materials. PDF
CDPH: COVID-19 Vaccination Program: Main Website Vaccination Planning: Webpage Q&A
DPH Resources
CDC Resources - Answering patients’ questions about COVID-19 vaccine:
FDA Resources
Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.
Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment
Medical professionals interested in supporting the COVID-19 response:
Vaccine trial data and information from FDA are below:
Pfizer-BioNTech
Moderna
Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.
Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.
